These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4026908)

  • 1. Variability in the pharmacokinetics of atenolol and metoprolol.
    Ledermann H; Bippi H; Boekens H; Frölich JC; Herrmann H; Schmitt-Landherr K
    Arzneimittelforschung; 1985; 35(5):848-51. PubMed ID: 4026908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aiming for steady 24-hour plasma concentrations: a comparison of two calcium antagonist and beta-blocker combinations.
    Eriksson M; Nyberg G; Lidman K; Olofsson B; Bergstrand R
    Blood Press Suppl; 1993; 1():16-21. PubMed ID: 7909705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O; Rydén L
    Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of beta-blockade with metoprolol and atenolol: influence of drug oxidation.
    Freestone S; Lennard MS; Silas JH; Ramsay LE
    Postgrad Med J; 1983; 59 Suppl 3():36-7. PubMed ID: 6647208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
    Nilsson OR; Atterhög JH; Castenfors J; Jorfelt L; Karlberg BE; Thulin T; Tolagen K; Wettre S; Ohman KP
    Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system kinetics of atenolol and metoprolol in the dog during long term treatment.
    Abrahamsson T; Lignell E; Mikulski A; Olovson SG; Regårdh CG
    Drug Metab Dispos; 1989; 17(1):82-6. PubMed ID: 2566475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.
    Freestone S; Silas JH; Lennard MS; Ramsay LE
    Br J Clin Pharmacol; 1982 Nov; 14(5):713-8. PubMed ID: 7138751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rifampicin on the pharmacokinetics of atenolol.
    Lilja JJ; Juntti-Patinen L; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):555-8. PubMed ID: 16700816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of itraconazole on the pharmacokinetics of atenolol.
    Lilja JJ; Backman JT; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):395-8. PubMed ID: 16364056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
    Tateishi T; Nakashima H; Shitou T; Kumagai Y; Ohashi K; Hosoda S; Ebihara A
    Eur J Clin Pharmacol; 1989; 36(1):67-70. PubMed ID: 2917591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol.
    Kendall MJ; Jack DB; Laugher SJ; Lobo J; Rolf Smith S
    Br J Clin Pharmacol; 1984 Sep; 18(3):331-5. PubMed ID: 6487472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectivity of acebutolol, atenolol, and metoprolol in healthy volunteers estimated by the extent the drugs occupy beta 2-receptors in the circulating plasma.
    Kaila T; Iisalo E
    J Clin Pharmacol; 1993 Oct; 33(10):959-66. PubMed ID: 8227468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of salicylates administered with metoprolol.
    Spahn H; Langguth P; Kirch W; Mutschler E; Ohnhaus EE
    Arzneimittelforschung; 1986 Nov; 36(11):1697-9. PubMed ID: 3814230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ranitidine on plasma metoprolol and atenolol concentrations.
    Spahn H; Mutschler E; Kirch W; Ohnhaus EE; Janisch HD
    Br Med J (Clin Res Ed); 1983 May; 286(6377):1546-7. PubMed ID: 6133576
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
    Hallengren B; Nilsson OR; Karlberg BE; Melander A; Tegler L; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1982; 21(5):379-84. PubMed ID: 7075643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
    Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
    N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of atenolol and metoprolol administered together with piroxicam.
    Spahn H; Langguth P; Krauss D; Kirch W; Mutschler E
    Arch Pharm (Weinheim); 1987 Feb; 320(2):103-7. PubMed ID: 3579517
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in serum phosphate during beta-blockade in healthy men are not due to changes in the renal handling of phosphate.
    Kayser L; Perrild H; Jørgensen B; Fogh-Andersen N; Mølholm Hansen JE
    J Intern Med; 1989 Mar; 225(3):197-200. PubMed ID: 2649632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence study of generic atenolol tablets in healthy Thai volunteers.
    Rojanasthien N; Manorot M; Kumsorn B
    J Med Assoc Thai; 1999 Sep; 82(9):907-14. PubMed ID: 10561948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.
    Johnsson G; Jordö L; Lundborg P; Regårdh CG; Rönn O
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):292-7. PubMed ID: 7000717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.